{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:59:00Z","timestamp":1789556340155,"version":"build-2803163510"},"reference-count":254,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T00:00:00Z","timestamp":1489536000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1038\/nrgastro.2016.154","type":"journal-article","created":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T01:17:44Z","timestamp":1489540664000},"page":"279-295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":145,"title":["Genetics of primary sclerosing cholangitis and pathophysiological implications"],"prefix":"10.1038","volume":"14","author":[{"given":"Xiaojun","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom H.","family":"Karlsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,15]]},"reference":[{"key":"BFnrgastro2016154_CR1","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","volume":"382","author":"GM Hirschfield","year":"2013","unstructured":"Hirschfield, G. M., Karlsen, T. H., Lindor, K. D. & Adams, D. H. Primary sclerosing cholangitis. Lancet 382, 1587\u20131599 (2013).","journal-title":"Lancet"},{"key":"BFnrgastro2016154_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/00365529850166284","volume":"33","author":"KM Boberg","year":"1998","unstructured":"Boberg, K. M.  et al. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand. J. Gastroenterol. 33, 99\u2013103 (1998).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro2016154_CR3","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1046\/j.1440-1746.2002.02835.x","volume":"17","author":"TL Ang","year":"2002","unstructured":"Ang, T. L.  et al. Clinical profile of primary sclerosing cholangitis in Singapore. J. Gastroenterol. Hepatol. 17, 908\u2013913 (2002).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016154_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1055\/s-2008-1040420","volume":"11","author":"O Fausa","year":"1991","unstructured":"Fausa, O., Schrumpf, E. & Elgjo, K. Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin. Liver Dis. 11, 31\u201339 (1991).","journal-title":"Semin. Liver Dis."},{"key":"BFnrgastro2016154_CR5","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3109\/00365529709025107","volume":"32","author":"HH Rasmussen","year":"1997","unstructured":"Rasmussen, H. H.  et al. Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn's disease. Scand. J. Gastroenterol. 32, 604\u2013610 (1997).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro2016154_CR6","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1053\/jhep.2002.33202","volume":"35","author":"P Angulo","year":"2002","unstructured":"Angulo, P., Maor-Kendler, Y. & Lindor, K. D. Small-duct primary sclerosing cholangitis: a long-term follow-up study. Hepatology 35, 1494\u20131500 (2002).","journal-title":"Hepatology"},{"key":"BFnrgastro2016154_CR7","first-page":"279","volume":"92","author":"TR Riley","year":"1997","unstructured":"Riley, T. R., Schoen, R. E., Lee, R. G. & Rakela, J. A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease. Am. J. Gastroenterol. 92, 279\u2013282 (1997).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2016154_CR8","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.crohns.2012.09.002","volume":"6","author":"A Dignass","year":"2012","unstructured":"Dignass, A.  et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. J. Crohns Colitis 6, 991\u20131030 (2012).","journal-title":"J. Crohns Colitis"},{"key":"BFnrgastro2016154_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/ecco-jcc\/jjv213","volume":"10","author":"M Harbord","year":"2016","unstructured":"Harbord, M.  et al. The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J. Crohns Colitis 10, 239\u2013254 (2016).","journal-title":"J. Crohns Colitis"},{"key":"BFnrgastro2016154_CR10","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/apt.12581","volume":"39","author":"TH Karlsen","year":"2014","unstructured":"Karlsen, T. H., Vesterhus, M. & Boberg, K. M. Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis. Aliment. Pharmacol. Ther. 39, 282\u2013301 (2014).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2016154_CR11","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/hep.26565","volume":"58","author":"K Boonstra","year":"2013","unstructured":"Boonstra, K.  et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology 58, 2045\u20132055 (2013).","journal-title":"Hepatology"},{"key":"BFnrgastro2016154_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0168-8278(00)80457-2","volume":"32","author":"KM Boberg","year":"2000","unstructured":"Boberg, K. M.  et al. Natural history of primary sclerosing cholangitis. A longterm follow-up study of 394 European primary sclerosing cholangitis patients. J. Hepatol. 32, 32 (2000).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016154_CR13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3109\/00365521.2015.1036359","volume":"50","author":"B Fosby","year":"2015","unstructured":"Fosby, B.  et al. Liver transplantation in the Nordic countries \u2014 an intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982\u20132013. Scand. J. Gastroenterol. 50, 797\u2013808 (2015).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro2016154_CR14","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","volume":"57","author":"R Adam","year":"2012","unstructured":"Adam, R.  et al. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J. Hepatol. 57, 675\u2013688 (2012).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016154_CR15","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1053\/bega.2001.0204","volume":"15","author":"E Schrumpf","year":"2001","unstructured":"Schrumpf, E. & Boberg, K. M. Epidemiology of primary sclerosing cholangitis. Best Pract. Res. Clin. Gastroenterol. 15, 553\u2013562 (2001).","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"BFnrgastro2016154_CR16","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0168-8278(94)80240-8","volume":"21","author":"A Escorsell","year":"1994","unstructured":"Escorsell, A.  et al. Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver. J. Hepatol. 21, 787\u2013791 (1994).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016154_CR17","first-page":"685","volume":"8","author":"L Okolicsanyi","year":"1996","unstructured":"Okolicsanyi, L.  et al. Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group. Eur. J. Gastroenterol. Hepatol. 8, 685\u2013691 (1996).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016154_CR18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1440-1746.1996.tb00286.x","volume":"11","author":"R Kochhar","year":"1996","unstructured":"Kochhar, R.  et al. Primary sclerosing cholangitis: an experience from India. J. Gastroenterol. Hepatol. 11, 429\u2013433 (1996).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016154_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.hepres.2004.03.006","volume":"29","author":"H Takikawa","year":"2004","unstructured":"Takikawa, H., Takamori, Y., Tanaka, A., Kurihara, H. & Nakanuma, Y. Analysis of 388 cases of primary sclerosing cholangitis in Japan; presence of a subgroup without pancreatic involvement in older patients. Hepatol. Res. 29, 153\u2013159 (2004).","journal-title":"Hepatol. Res."},{"key":"BFnrgastro2016154_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jaut.2013.07.004","volume":"46","author":"GF Mells","year":"2013","unstructured":"Mells, G. F., Kaser, A. & Karlsen, T. H. Novel insights into autoimmune liver diseases provided by genome-wide association studies. J. Autoimmun. 46, 41\u201354 (2013).","journal-title":"J. Autoimmun."},{"key":"BFnrgastro2016154_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cld.2015.08.014","volume":"20","author":"T Folseraas","year":"2016","unstructured":"Folseraas, T. & Boberg, K. M. Cancer risk and surveillance in primary sclerosing cholangitis. Clin. Liver Dis. 20, 79\u201398 (2016).","journal-title":"Clin. Liver Dis."},{"key":"BFnrgastro2016154_CR22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1478-3231.2012.02765.x","volume":"32","author":"MB de Valle","year":"2012","unstructured":"de Valle, M. B., Bjornsson, E. & Lindkvist, B. Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort. Liver Int. 32, 441\u2013448 (2012).","journal-title":"Liver Int."},{"key":"BFnrgastro2016154_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/jhbp.50","volume":"21","author":"A Tanaka","year":"2014","unstructured":"Tanaka, A.  et al. Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan. J. Hepatobiliary Pancreat. Sci. 21, 43\u201350 (2014).","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"BFnrgastro2016154_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/jhbp.194","volume":"22","author":"A Tanaka","year":"2015","unstructured":"Tanaka, A.  et al. Clinical profiles of patients with primary sclerosing cholangitis in the elderly. J. Hepatobiliary Pancreat. Sci. 22, 230\u2013236 (2015).","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"BFnrgastro2016154_CR25","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1053\/j.gastro.2016.06.021","volume":"151","author":"AK Lunder","year":"2016","unstructured":"Lunder, A. K.  et al. Prevalence of sclerosing cholangitis, detected by magnetic resonance cholangiography, in patients with long-term inflammatory bowel disease. Gastroenterology 151, 660\u2013669.e4 (2016).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016154_CR26","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/ibd.21699","volume":"18","author":"KK Jorgensen","year":"2012","unstructured":"Jorgensen, K. K.  et al. Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients. Inflamm. Bowel Dis. 18, 536\u2013545 (2012).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2016154_CR27","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/hmg\/4.7.1183","volume":"4","author":"O Koiwai","year":"1995","unstructured":"Koiwai, O.  et al. Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase. Hum. Mol. Genet. 4, 1183\u20131186 (1995).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrgastro2016154_CR28","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1096\/fasebj.6.10.1634050","volume":"6","author":"PJ Bosma","year":"1992","unstructured":"Bosma, P. J.  et al. Mechanisms of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type I. FASEB J. 6, 2859\u20132863 (1992).","journal-title":"FASEB J."},{"key":"BFnrgastro2016154_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1006\/geno.1993.1451","volume":"18","author":"N Moghrabi","year":"1993","unstructured":"Moghrabi, N., Clarke, D. J., Boxer, M. & Burchell, B. Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2. Genomics 18, 171\u2013173 (1993).","journal-title":"Genomics"},{"key":"BFnrgastro2016154_CR30","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/ng1293-338","volume":"5","author":"K Petrukhin","year":"1993","unstructured":"Petrukhin, K.  et al. Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nat. Genet. 5, 338\u2013343 (1993).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/ng1293-327","volume":"5","author":"PC Bull","year":"1993","unstructured":"Bull, P. C., Thomas, G. R., Rommens, J. M., Forbes, J. R. & Cox, D. W. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat. Genet. 5, 327\u2013337 (1993).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR32","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/hep.510250635","volume":"25","author":"CC Paulusma","year":"1997","unstructured":"Paulusma, C. C.  et al. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 25, 1539\u20131542 (1997).","journal-title":"Hepatology"},{"key":"BFnrgastro2016154_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/ng1274","volume":"36","author":"G Papanikolaou","year":"2004","unstructured":"Papanikolaou, G.  et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat. Genet. 36, 77\u201382 (2004).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/ng1053","volume":"33","author":"A Roetto","year":"2003","unstructured":"Roetto, A.  et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat. Genet. 33, 21\u201322 (2003).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR35","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/90038","volume":"28","author":"OT Njajou","year":"2001","unstructured":"Njajou, O. T.  et al. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat. Genet. 28, 213\u2013214 (2001).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR36","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1172\/JCI200113468","volume":"108","author":"G Montosi","year":"2001","unstructured":"Montosi, G.  et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J. Clin. Invest. 108, 619\u2013623 (2001).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro2016154_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/3034","volume":"20","author":"SS Strautnieks","year":"1998","unstructured":"Strautnieks, S. S.  et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat. Genet. 20, 233\u2013238 (1998).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR38","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/ng0398-219","volume":"18","author":"LN Bull","year":"1998","unstructured":"Bull, L. N.  et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat. Genet. 18, 219\u2013224 (1998).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1086\/505332","volume":"79","author":"R McDaniell","year":"2006","unstructured":"McDaniell, R.  et al. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am. J. Hum. Genet. 79, 169\u2013173 (2006).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrgastro2016154_CR40","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/ng0896-399","volume":"13","author":"JN Feder","year":"1996","unstructured":"Feder, J. N.  et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 13, 399\u2013408 (1996).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR41","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1136\/jmedgenet-2011-100544","volume":"49","author":"BM Kamath","year":"2012","unstructured":"Kamath, B. M.  et al. NOTCH2 mutations in Alagille syndrome. J. Med. Genet. 49, 138\u2013144 (2012).","journal-title":"J. Med. Genet."},{"key":"BFnrgastro2016154_CR42","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1073\/pnas.95.1.282","volume":"95","author":"JM de Vree","year":"1998","unstructured":"de Vree, J. M.  et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc. Natl Acad. Sci. USA 95, 282\u2013287 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2016154_CR43","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1053\/gast.2002.32984","volume":"122","author":"D Girelli","year":"2002","unstructured":"Girelli, D.  et al. Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene. Gastroenterology 122, 1295\u20131302 (2002).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016154_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/79866","volume":"26","author":"KM Weiss","year":"2000","unstructured":"Weiss, K. M. & Terwilliger, J. D. How many diseases does it take to map a gene with SNPs? Nat. Genet. 26, 151\u2013157 (2000).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR45","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/MOG.0000000000000052","volume":"30","author":"EK Henriksen","year":"2014","unstructured":"Henriksen, E. K., Melum, E. & Karlsen, T. H. Update on primary sclerosing cholangitis genetics. Curr. Opin. Gastroenterol. 30, 310\u2013319 (2014).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"BFnrgastro2016154_CR46","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/ng.2232","volume":"44","author":"EA Stahl","year":"2012","unstructured":"Stahl, E. A.  et al. Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis. Nat. Genet. 44, 483\u2013489 (2012).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR47","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/ng.3097","volume":"46","author":"AR Wood","year":"2014","unstructured":"Wood, A. R.  et al. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat. Genet. 46, 1173\u20131186 (2014).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR48","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1126\/science.1109557","volume":"308","author":"RJ Klein","year":"2005","unstructured":"Klein, R. J.  et al. Complement factor H polymorphism in age-related macular degeneration. Science 308, 385\u2013389 (2005).","journal-title":"Science"},{"key":"BFnrgastro2016154_CR49","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nrg777","volume":"3","author":"KG Ardlie","year":"2002","unstructured":"Ardlie, K. G., Kruglyak, L. & Seielstad, M. Patterns of linkage disequilibrium in the human genome. Nat. Rev. Genet. 3, 299\u2013309 (2002).","journal-title":"Nat. Rev. Genet."},{"key":"BFnrgastro2016154_CR50","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/mi.2007.15","volume":"1","author":"P Goyette","year":"2008","unstructured":"Goyette, P.  et al. Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis. Mucosal Immunol. 1, 131\u2013138 (2008).","journal-title":"Mucosal Immunol."},{"key":"BFnrgastro2016154_CR51","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/nrg1489","volume":"5","author":"R Horton","year":"2004","unstructured":"Horton, R.  et al. Gene map of the extended human MHC. Nat. Rev. Genet. 5, 889\u2013899 (2004).","journal-title":"Nat. Rev. Genet."},{"key":"BFnrgastro2016154_CR52","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrg2344","volume":"9","author":"MI McCarthy","year":"2008","unstructured":"McCarthy, M. I.  et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat. Rev. Genet. 9, 356\u2013369 (2008).","journal-title":"Nat. Rev. Genet."},{"key":"BFnrgastro2016154_CR53","doi-asserted-by":"publisher","first-page":"9362","DOI":"10.1073\/pnas.0903103106","volume":"106","author":"LA Hindorff","year":"2009","unstructured":"Hindorff, L. A.  et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl Acad. Sci. USA 106, 9362\u20139367 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2016154_CR54","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/ng.1052","volume":"44","author":"BK Bulik-Sullivan","year":"2012","unstructured":"Bulik-Sullivan, B. K. & Sullivan, P. F. The authorship network of genome-wide association studies. Nat. Genet. 44, 113 (2012).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR55","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/ng.2616","volume":"45","author":"JZ Liu","year":"2013","unstructured":"Liu, J. Z.  et al. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat. Genet. 45, 670\u2013675 (2013).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR56","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/ng.3528","volume":"48","author":"D Ellinghaus","year":"2016","unstructured":"Ellinghaus, D.  et al. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat. Genet. 48, 510\u2013518 (2016).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR57","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/ng.3745","volume":"49","author":"SG Ji","year":"2017","unstructured":"Ji, S. G.  et al. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease. Nat. Genet. 49, 269\u2013273 (2017).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR58","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.cgh.2008.03.016","volume":"6","author":"A Bergquist","year":"2008","unstructured":"Bergquist, A.  et al. Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis. Clin. Gastroenterol. Hepatol. 6, 939\u2013943 (2008).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016154_CR59","doi-asserted-by":"publisher","first-page":"e1000540","DOI":"10.1371\/journal.pgen.1000540","volume":"5","author":"DG Clayton","year":"2009","unstructured":"Clayton, D. G. Prediction and interaction in complex disease genetics: experience in type 1 diabetes. PLoS Genet. 5, e1000540 (2009).","journal-title":"PLoS Genet."},{"issue":"Suppl. 1","key":"BFnrgastro2016154_CR60","doi-asserted-by":"publisher","first-page":"R161","DOI":"10.1093\/hmg\/ddh079","volume":"13","author":"CG Mathew","year":"2004","unstructured":"Mathew, C. G. & Lewis, C. M. Genetics of inflammatory bowel disease: progress and prospects. Hum. Mol. Genet. 13 (Suppl. 1), R161\u2013R168 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrgastro2016154_CR61","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1136\/gut.2003.031732","volume":"53","author":"PT Donaldson","year":"2004","unstructured":"Donaldson, P. T. Genetics of liver disease: immunogenetics and disease pathogenesis. Gut 53, 599\u2013608 (2004).","journal-title":"Gut"},{"key":"BFnrgastro2016154_CR62","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/gut.21.10.870","volume":"21","author":"RW Chapman","year":"1980","unstructured":"Chapman, R. W.  et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 21, 870\u2013877 (1980).","journal-title":"Gut"},{"key":"BFnrgastro2016154_CR63","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jaut.2009.03.005","volume":"33","author":"P Invernizzi","year":"2009","unstructured":"Invernizzi, P., Pasini, S., Selmi, C., Gershwin, M. E. & Podda, M. Female predominance and X chromosome defects in autoimmune diseases. J. Autoimmun. 33, 12\u201316 (2009).","journal-title":"J. Autoimmun."},{"key":"BFnrgastro2016154_CR64","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"J Braun","year":"2007","unstructured":"Braun, J. & Sieper, J. Ankylosing spondylitis. Lancet 369, 1379\u20131390 (2007).","journal-title":"Lancet"},{"key":"BFnrgastro2016154_CR65","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.3748\/wjg.14.3781","volume":"14","author":"JR Hov","year":"2008","unstructured":"Hov, J. R., Boberg, K. M. & Karlsen, T. H. Autoantibodies in primary sclerosing cholangitis. World J. Gastroenterol. 14, 3781\u20133791 (2008).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro2016154_CR66","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1002\/hep.28116","volume":"63","author":"E Liaskou","year":"2016","unstructured":"Liaskou, E.  et al. High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires. Hepatology 63, 1608\u20131619 (2016).","journal-title":"Hepatology"},{"key":"BFnrgastro2016154_CR67","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.dld.2010.01.011","volume":"42","author":"TH Karlsen","year":"2010","unstructured":"Karlsen, T. H., Schrumpf, E. & Boberg, K. M. Update on primary sclerosing cholangitis. Dig. Liver Dis. 42, 390\u2013400 (2010).","journal-title":"Dig. Liver Dis."},{"key":"BFnrgastro2016154_CR68","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S0140-6736(02)07374-9","volume":"359","author":"AJ Grant","year":"2002","unstructured":"Grant, A. J., Lalor, P. F., Salmi, M., Jalkanen, S. & Adams, D. H. Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease. Lancet 359, 150\u2013157 (2002).","journal-title":"Lancet"},{"key":"BFnrgastro2016154_CR69","doi-asserted-by":"publisher","first-page":"S290","DOI":"10.1111\/j.1440-1746.2004.03690.x","volume":"19","author":"KM Das","year":"2004","unstructured":"Das, K. M. Immunopathogenesis of primary sclerosing cholangitis: possible role of a shared colonic and biliary epithelial antigen. J. Gastroenterol. Hepatol. 19, S290\u2013S294 (2004).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016154_CR70","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nrg2489","volume":"10","author":"A Zhernakova","year":"2009","unstructured":"Zhernakova, A., van Diemen, C. C. & Wijmenga, C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat. Rev. Genet. 10, 43\u201355 (2009).","journal-title":"Nat. Rev. Genet."},{"key":"BFnrgastro2016154_CR71","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/ng.3604","volume":"48","author":"PM Visscher","year":"2016","unstructured":"Visscher, P. M. & Yang, J. A plethora of pleiotropy across complex traits. Nat. Genet. 48, 707\u2013708 (2016).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR72","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/ng.3572","volume":"48","author":"B Han","year":"2016","unstructured":"Han, B.  et al. A method to decipher pleiotropy by detecting underlying heterogeneity driven by hidden subgroups applied to autoimmune and neuropsychiatric diseases. Nat. Genet. 48, 803\u2013810 (2016).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR73","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature13835","volume":"518","author":"KK Farh","year":"2015","unstructured":"Farh, K. K.  et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518, 337\u2013343 (2015).","journal-title":"Nature"},{"key":"BFnrgastro2016154_CR74","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/gut.2004.046615","volume":"54","author":"EV Loftus Jr","year":"2005","unstructured":"Loftus, E. V. Jr  et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 54, 91\u201396 (2005).","journal-title":"Gut"},{"key":"BFnrgastro2016154_CR75","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nri1784","volume":"6","author":"DH Adams","year":"2006","unstructured":"Adams, D. H. & Eksteen, B. Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease. Nat. Rev. Immunol. 6, 244\u2013251 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrgastro2016154_CR76","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature11582","volume":"491","author":"L Jostins","year":"2012","unstructured":"Jostins, L.  et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119\u2013124 (2012).","journal-title":"Nature"},{"key":"BFnrgastro2016154_CR77","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/ng.3359","volume":"47","author":"JZ Liu","year":"2015","unstructured":"Liu, J. Z.  et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat. Genet. 47, 979\u2013986 (2015).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR78","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/sj.gene.6364377","volume":"8","author":"TH Karlsen","year":"2007","unstructured":"Karlsen, T. H.  et al. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis. Genes Immun. 8, 275\u2013278 (2007).","journal-title":"Genes Immun."},{"key":"BFnrgastro2016154_CR79","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","volume":"147","author":"YS de Boer","year":"2014","unstructured":"de Boer, Y. S.  et al. Genome-wide association study identifies variants associated with autoimmune hepatitis type 1. Gastroenterology 147, 443\u2013452.e5 (2014).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016154_CR80","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1053\/j.gastro.2014.06.020","volume":"147","author":"GM Hirschfield","year":"2014","unstructured":"Hirschfield, G. M. & Karlsen, T. H. Genetic risks link autoimmune hepatitis to other autoimmune liver disease. Gastroenterology 147, 270\u2013273 (2014).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016154_CR81","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0168-8278(00)80004-5","volume":"33","author":"M Kaya","year":"2000","unstructured":"Kaya, M., Angulo, P. & Lindor, K. D. Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system. J. Hepatol. 33, 537\u2013542 (2000).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016154_CR82","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/gutjnl-2015-309458","volume":"65","author":"M Reich","year":"2016","unstructured":"Reich, M.  et al. TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro. Gut 65, 487\u2013501 (2016).","journal-title":"Gut"},{"key":"BFnrgastro2016154_CR83","doi-asserted-by":"publisher","first-page":"e12403","DOI":"10.1371\/journal.pone.0012403","volume":"5","author":"JR Hov","year":"2010","unstructured":"Hov, J. R.  et al. Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis. PLoS ONE 5, e12403 (2010).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2016154_CR84","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s12016-014-8443-x","volume":"48","author":"V Keitel","year":"2015","unstructured":"Keitel, V., Reich, M. & Haussinger, D. TGR5: pathogenetic role and\/or therapeutic target in fibrosing cholangitis? Clin. Rev. Allergy Immunol. 48, 218\u2013225 (2015).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"BFnrgastro2016154_CR85","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1053\/j.gastro.2006.05.057","volume":"131","author":"TH Karlsen","year":"2006","unstructured":"Karlsen, T. H.  et al. Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis. Gastroenterology 131, 781\u2013787 (2006).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016154_CR86","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1073\/pnas.051551698","volume":"98","author":"JL Staudinger","year":"2001","unstructured":"Staudinger, J. L.  et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc. Natl Acad. Sci. USA 98, 3369\u20133374 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2016154_CR87","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1744-313X.2008.00765.x","volume":"35","author":"JA Traherne","year":"2008","unstructured":"Traherne, J. A. Human MHC architecture and evolution: implications for disease association studies. Int. J. Immunogenet. 35, 179\u2013192 (2008).","journal-title":"Int. J. Immunogenet."},{"key":"BFnrgastro2016154_CR88","volume-title":"The HLA FactsBook","author":"SGE Marsh","year":"2000","unstructured":"Marsh, S. G. E., Parham, P. & Barber, L. D. The HLA FactsBook (Academic Press, 2000)."},{"key":"BFnrgastro2016154_CR89","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nm0698-713","volume":"4","author":"O Molberg","year":"1998","unstructured":"Molberg, O.  et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat. Med. 4, 713\u2013717 (1998).","journal-title":"Nat. Med."},{"key":"BFnrgastro2016154_CR90","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1084\/jem.169.1.345","volume":"169","author":"LM Sollid","year":"1989","unstructured":"Sollid, L. M.  et al. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha\/beta heterodimer. J. Exp. Med. 169, 345\u2013350 (1989).","journal-title":"J. Exp. Med."},{"key":"BFnrgastro2016154_CR91","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1053\/jhep.2001.27543","volume":"34","author":"K Wiencke","year":"2001","unstructured":"Wiencke, K., Spurkland, A., Schrumpf, E. & Boberg, K. M. Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles. Hepatology 34, 625\u2013630 (2001).","journal-title":"Hepatology"},{"key":"BFnrgastro2016154_CR92","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0168-8278(99)80068-3","volume":"30","author":"W Bernal","year":"1999","unstructured":"Bernal, W., Moloney, M., Underhill, J. & Donaldson, P. T. Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis. J. Hepatol. 30, 237\u2013241 (1999).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016154_CR93","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/ng.3176","volume":"47","author":"P Goyette","year":"2015","unstructured":"Goyette, P.  et al. High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nat. Genet. 47, 172\u2013179 (2015).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR94","doi-asserted-by":"publisher","first-page":"e114486","DOI":"10.1371\/journal.pone.0114486","volume":"9","author":"S Naess","year":"2014","unstructured":"Naess, S.  et al. Refinement of the MHC risk map in a scandinavian primary sclerosing cholangitis population. PLoS ONE 9, e114486 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2016154_CR95","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.coi.2005.07.001","volume":"17","author":"BA Lie","year":"2005","unstructured":"Lie, B. A. & Thorsby, E. Several genes in the extended human MHC contribute to predisposition to autoimmune diseases. Curr. Opin. Immunol. 17, 526\u2013531 (2005).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnrgastro2016154_CR96","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1126\/science.1074129","volume":"297","author":"L Shan","year":"2002","unstructured":"Shan, L.  et al. Structural basis for gluten intolerance in celiac sprue. Science 297, 2275\u20132279 (2002).","journal-title":"Science"},{"key":"BFnrgastro2016154_CR97","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/hep.24299","volume":"53","author":"JR Hov","year":"2011","unstructured":"Hov, J. R.  et al. Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis. Hepatology 53, 1967\u20131976 (2011).","journal-title":"Hepatology"},{"key":"BFnrgastro2016154_CR98","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1002\/lt.22161","volume":"16","author":"CL Bowlus","year":"2010","unstructured":"Bowlus, C. L., Li, C. S., Karlsen, T. H., Lie, B. A. & Selmi, C. Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: unique clinical and human leukocyte antigen associations. Liver Transpl. 16, 1324\u20131330 (2010).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2016154_CR99","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1053\/j.gastro.2009.11.046","volume":"138","author":"TH Karlsen","year":"2010","unstructured":"Karlsen, T. H.  et al. Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology 138, 1102\u20131111 (2010).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016154_CR100","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/hmg\/ddg066","volume":"12","author":"T Ahmad","year":"2003","unstructured":"Ahmad, T.  et al. Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC. Hum. Mol. Genet. 12, 647\u2013656 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrgastro2016154_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00251-007-0262-2","volume":"60","author":"R Horton","year":"2008","unstructured":"Horton, R.  et al. Variation analysis and gene annotation of eight MHC haplotypes: the MHC Haplotype Project. Immunogenetics 60, 1\u201318 (2008).","journal-title":"Immunogenetics"},{"key":"BFnrgastro2016154_CR102","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/sj.gene.6364272","volume":"7","author":"A Blomhoff","year":"2006","unstructured":"Blomhoff, A.  et al. Linkage disequilibrium and haplotype blocks in the MHC vary in an HLA haplotype specific manner assessed mainly by DRB1*03 and DRB1*04 haplotypes. Genes Immun. 7, 130\u2013140 (2006).","journal-title":"Genes Immun."},{"key":"BFnrgastro2016154_CR103","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/00365528209182038","volume":"17","author":"E Schrumpf","year":"1982","unstructured":"Schrumpf, E.  et al. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand. J. Gastroenterol. 17, 187\u2013191 (1982).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro2016154_CR104","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1399-0039.2009.01291.x","volume":"74","author":"E Thorsby","year":"2009","unstructured":"Thorsby, E. A short history of HLA. Tissue Antigens 74, 101\u2013116 (2009).","journal-title":"Tissue Antigens"},{"key":"BFnrgastro2016154_CR105","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.3748\/wjg.v13.i41.5421","volume":"13","author":"TH Karlsen","year":"2007","unstructured":"Karlsen, T. H., Schrumpf, E. & Boberg, K. M. Genetic epidemiology of primary sclerosing cholangitis. World J. Gastroenterol. 13, 5421\u20135431 (2007).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro2016154_CR106","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng.728","volume":"43","author":"E Melum","year":"2011","unstructured":"Melum, E.  et al. Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat. Genet. 43, 17\u201319 (2011).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR107","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3109\/00365521.2012.682090","volume":"47","author":"B Srivastava","year":"2012","unstructured":"Srivastava, B.  et al. Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis. Scand. J. Gastroenterol. 47, 820\u2013826 (2012).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro2016154_CR108","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jhep.2012.03.031","volume":"57","author":"T Folseraas","year":"2012","unstructured":"Folseraas, T.  et al. Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci. J. Hepatol. 57, 366\u2013375 (2012).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016154_CR109","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/hep.25977","volume":"58","author":"D Ellinghaus","year":"2013","unstructured":"Ellinghaus, D.  et al. Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4. Hepatology 58, 1074\u20131083 (2013).","journal-title":"Hepatology"},{"key":"BFnrgastro2016154_CR110","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s12016-014-8417-z","volume":"48","author":"T Folseraas","year":"2015","unstructured":"Folseraas, T., Liaskou, E., Anderson, C. A. & Karlsen, T. H. Genetics in PSC: what do the \u201crisk genes\u201d teach us? Clin. Rev. Allergy Immunol. 48, 154\u2013164 (2015).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"BFnrgastro2016154_CR111","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale, J.  et al. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580\u2013585 (2013).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR112","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/cmi.2016.09","volume":"13","author":"B Gao","year":"2016","unstructured":"Gao, B. Basic liver immunology. Cell. Mol. Immunol. 13, 265\u2013266 (2016).","journal-title":"Cell. Mol. Immunol."},{"key":"BFnrgastro2016154_CR113","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1053\/j.gastro.2011.06.052","volume":"141","author":"R Fiorotto","year":"2011","unstructured":"Fiorotto, R.  et al. Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-kappaB-mediated inflammatory response in mice. Gastroenterology 141, 1498\u20131508.e5 (2011).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016154_CR114","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2009.09.026","volume":"16","author":"D Zhou","year":"2009","unstructured":"Zhou, D.  et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 16, 425\u2013438 (2009).","journal-title":"Cancer Cell"},{"key":"BFnrgastro2016154_CR115","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1073\/pnas.0911409107","volume":"107","author":"H Song","year":"2010","unstructured":"Song, H.  et al. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc. Natl Acad. Sci. USA 107, 1431\u20131436 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2016154_CR116","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.dld.2012.12.017","volume":"45","author":"M Krawczyk","year":"2013","unstructured":"Krawczyk, M.  et al. Macrophage stimulating protein variation enhances the risk of sporadic extrahepatic cholangiocarcinoma. Dig. Liver Dis. 45, 612\u2013615 (2013).","journal-title":"Dig. Liver Dis."},{"key":"BFnrgastro2016154_CR117","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1073\/pnas.0911427107","volume":"107","author":"L Lu","year":"2010","unstructured":"Lu, L.  et al. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc. Natl Acad. Sci. USA 107, 1437\u20131442 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2016154_CR118","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1042\/BJ20080035","volume":"412","author":"A Soufi","year":"2008","unstructured":"Soufi, A. & Jayaraman, P. S. PRH\/Hex: an oligomeric transcription factor and multifunctional regulator of cell fate. Biochem. J. 412, 399\u2013413 (2008).","journal-title":"Biochem. J."},{"key":"BFnrgastro2016154_CR119","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s12032-011-9989-6","volume":"29","author":"J Su","year":"2012","unstructured":"Su, J.  et al. A potential role for the homeoprotein Hhex in hepatocellular carcinoma progression. Med. Oncol. 29, 1059\u20131067 (2012).","journal-title":"Med. Oncol."},{"key":"BFnrgastro2016154_CR120","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ydbio.2007.05.028","volume":"308","author":"MP Hunter","year":"2007","unstructured":"Hunter, M. P.  et al. The homeobox gene Hhex is essential for proper hepatoblast differentiation and bile duct morphogenesis. Dev. Biol. 308, 355\u2013367 (2007).","journal-title":"Dev. Biol."},{"key":"BFnrgastro2016154_CR121","doi-asserted-by":"publisher","first-page":"e90791","DOI":"10.1371\/journal.pone.0090791","volume":"9","author":"H Watanabe","year":"2014","unstructured":"Watanabe, H.  et al. HHEX promotes hepatic-lineage specification through the negative regulation of eomesodermin. PLoS ONE 9, e90791 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2016154_CR122","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10875-016-0232-2","volume":"36","author":"TS Dang","year":"2016","unstructured":"Dang, T. S.  et al. Defective leukocyte adhesion and chemotaxis contributes to combined immunodeficiency in humans with autosomal recessive MST1 deficiency. J. Clin. Immunol. 36, 117\u2013122 (2016).","journal-title":"J. Clin. Immunol."},{"key":"BFnrgastro2016154_CR123","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1136\/gut.8.5.435","volume":"8","author":"ME Thorpe","year":"1967","unstructured":"Thorpe, M. E., Scheuer, P. J. & Sherlock, S. Primary sclerosing cholangitis, the biliary tree, and ulcerative colitis. Gut 8, 435\u2013448 (1967).","journal-title":"Gut"},{"key":"BFnrgastro2016154_CR124","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0002-9610(66)90339-4","volume":"111","author":"KW Warren","year":"1966","unstructured":"Warren, K. W., Athanassiades, S. & Monge, J. I. Primary sclerosing cholangitis. A study of forty-two cases. Am. J. Surg. 111, 23\u201338 (1966).","journal-title":"Am. J. Surg."},{"key":"BFnrgastro2016154_CR125","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/hep.1840130425","volume":"13","author":"SN Lichtman","year":"1991","unstructured":"Lichtman, S. N., Keku, J., Clark, R. L., Schwab, J. H. & Sartor, R. B. Biliary tract disease in rats with experimental small bowel bacterial overgrowth. Hepatology 13, 766\u2013772 (1991).","journal-title":"Hepatology"},{"key":"BFnrgastro2016154_CR126","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1136\/gut.2007.122168","volume":"57","author":"DH Adams","year":"2008","unstructured":"Adams, D. H., Eksteen, B. & Curbishley, S. M. Immunology of the gut and liver: a love\/hate relationship. Gut 57, 838\u2013848 (2008).","journal-title":"Gut"},{"key":"BFnrgastro2016154_CR127","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/00007890-199802150-00017","volume":"65","author":"AS Befeler","year":"1998","unstructured":"Befeler, A. S.  et al. Clinical course and management of inflammatory bowel disease after liver transplantation. Transplantation 65, 393\u2013396 (1998).","journal-title":"Transplantation"},{"key":"BFnrgastro2016154_CR128","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3109\/00365528009181516","volume":"15","author":"E Schrumpf","year":"1980","unstructured":"Schrumpf, E.  et al. Sclerosing cholangitis in ulcerative colitis. Scand. J. Gastroenterol. 15, 689\u2013697 (1980).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro2016154_CR129","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ajhg.2008.09.012","volume":"83","author":"X Yuan","year":"2008","unstructured":"Yuan, X.  et al. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am. J. Hum. Genet. 83, 520\u2013528 (2008).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrgastro2016154_CR130","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/ng.970","volume":"43","author":"JC Chambers","year":"2011","unstructured":"Chambers, J. C.  et al. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat. Genet. 43, 1131\u20131138 (2011).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR131","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.jhep.2013.08.005","volume":"59","author":"A Wannhoff","year":"2013","unstructured":"Wannhoff, A.  et al. FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis. J. Hepatol. 59, 1278\u20131284 (2013).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016154_CR132","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.1233521","volume":"339","author":"JG Markle","year":"2013","unstructured":"Markle, J. G.  et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339, 1084\u20131088 (2013).","journal-title":"Science"},{"key":"BFnrgastro2016154_CR133","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nrmicro2540","volume":"9","author":"A Spor","year":"2011","unstructured":"Spor, A., Koren, O. & Ley, R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat. Rev. Microbiol. 9, 279\u2013290 (2011).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFnrgastro2016154_CR134","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/ecco-jcc\/jjv204","volume":"10","author":"D Kevans","year":"2016","unstructured":"Kevans, D.  et al. Characterization of intestinal microbiota in ulcerative colitis patients with and without primary sclerosing cholangitis. J. Crohns Colitis 10, 330\u2013337 (2016).","journal-title":"J. Crohns Colitis"},{"key":"BFnrgastro2016154_CR135","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/ecco-jcc\/jju023","volume":"9","author":"NG Rossen","year":"2015","unstructured":"Rossen, N. G.  et al. The mucosa-associated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured Clostridiales II. J. Crohns Colitis 9, 342\u2013348 (2015).","journal-title":"J. Crohns Colitis"},{"key":"BFnrgastro2016154_CR136","doi-asserted-by":"publisher","unstructured":"Kummen, M.  et al. The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls. Gut \n                    http:\/\/dx.doi.org\/10.1136\/gutjnl-2015-310500\n                    \n                   (2016).","DOI":"10.1136\/gutjnl-2015-310500"},{"key":"BFnrgastro2016154_CR137","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/apt.13552","volume":"43","author":"J Torres","year":"2016","unstructured":"Torres, J.  et al. The features of mucosa-associated microbiota in primary sclerosing cholangitis. Aliment. Pharmacol. Ther. 43, 790\u2013801 (2016).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2016154_CR138","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1136\/gutjnl-2016-311915","volume":"66","author":"MN Quraishi","year":"2017","unstructured":"Quraishi, M. N.  et al. The gut-adherent microbiota of PSC-IBD is distinct to that of IBD. Gut 66, 386\u2013388 (2017).","journal-title":"Gut"},{"key":"BFnrgastro2016154_CR139","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","volume":"65","author":"J Sabino","year":"2017","unstructured":"Sabino, J.  et al. Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD. Gut 65, 1681\u20131689 (2017).","journal-title":"Gut"},{"key":"BFnrgastro2016154_CR140","doi-asserted-by":"publisher","unstructured":"Ruhlemann, M. C.  et al. Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis. Gut \n                    http:\/\/dx.doi.org\/10.1136\/gutjnl-2016-312180\n                    \n                   (2016).","DOI":"10.1136\/gutjnl-2016-312180"},{"key":"BFnrgastro2016154_CR141","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4049\/jimmunol.1401704","volume":"194","author":"JL Maravillas-Montero","year":"2015","unstructured":"Maravillas-Montero, J. L.  et al. Cutting edge: GPR35\/CXCR8 is the receptor of the mucosal chemokine CXCL17. J. Immunol. 194, 29\u201333 (2015).","journal-title":"J. Immunol."},{"key":"BFnrgastro2016154_CR142","doi-asserted-by":"publisher","first-page":"22021","DOI":"10.1074\/jbc.M603503200","volume":"281","author":"J Wang","year":"2006","unstructured":"Wang, J.  et al. Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J. Biol. Chem. 281, 22021\u201322028 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro2016154_CR143","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00726-008-0183-x","volume":"37","author":"P Paluszkiewicz","year":"2009","unstructured":"Paluszkiewicz, P.  et al. High concentration of kynurenic acid in bile and pancreatic juice. Amino Acids 37, 637\u2013641 (2009).","journal-title":"Amino Acids"},{"key":"BFnrgastro2016154_CR144","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nm.2092","volume":"16","author":"Y Wang","year":"2010","unstructured":"Wang, Y.  et al. Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nat. Med. 16, 279\u2013285 (2010).","journal-title":"Nat. Med."},{"key":"BFnrgastro2016154_CR145","doi-asserted-by":"publisher","first-page":"19189","DOI":"10.1074\/jbc.M109.024042","volume":"284","author":"MC Barth","year":"2009","unstructured":"Barth, M. C.  et al. Kynurenic acid triggers firm arrest of leukocytes to vascular endothelium under flow conditions. J. Biol. Chem. 284, 19189\u201319195 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro2016154_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MIB.0000000000000268","volume":"21","author":"SK Yang","year":"2015","unstructured":"Yang, S. K.  et al. Immunochip analysis identification of 6 additional susceptibility loci for Crohn's disease in Koreans. Inflamm. Bowel Dis. 21, 1\u20137 (2015).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2016154_CR147","doi-asserted-by":"publisher","first-page":"5284","DOI":"10.4049\/jimmunol.1402016","volume":"193","author":"Z Kellermayer","year":"2014","unstructured":"Kellermayer, Z.  et al. Absence of Nkx2-3 homeodomain transcription factor reprograms the endothelial addressin preference for lymphocyte homing in Peyer's patches. J. Immunol. 193, 5284\u20135293 (2014).","journal-title":"J. Immunol."},{"key":"BFnrgastro2016154_CR148","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1155\/2012\/340204","volume":"32","author":"W Yu","year":"2012","unstructured":"Yu, W.  et al. PTPN2 is associated with Crohn's disease and its expression is regulated by NKX2-3. Dis. Markers 32, 83\u201391 (2012).","journal-title":"Dis. Markers"},{"key":"BFnrgastro2016154_CR149","doi-asserted-by":"publisher","first-page":"5846","DOI":"10.1074\/jbc.272.9.5846","volume":"272","author":"K Hieshima","year":"1997","unstructured":"Hieshima, K.  et al. Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2. J. Biol. Chem. 272, 5846\u20135853 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro2016154_CR150","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/mi.2012.23","volume":"5","author":"AL Frantz","year":"2012","unstructured":"Frantz, A. L.  et al. Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immunoglobulin receptor, mucin-2, and antibacterial peptides. Mucosal Immunol. 5, 501\u2013512 (2012).","journal-title":"Mucosal Immunol."},{"key":"BFnrgastro2016154_CR151","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1126\/science.1255904","volume":"345","author":"HS Kuehn","year":"2014","unstructured":"Kuehn, H. S.  et al. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science 345, 1623\u20131627 (2014).","journal-title":"Science"},{"key":"BFnrgastro2016154_CR152","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/nm.3746","volume":"20","author":"D Schubert","year":"2014","unstructured":"Schubert, D.  et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat. Med. 20, 1410\u20131416 (2014).","journal-title":"Nat. Med."},{"key":"BFnrgastro2016154_CR153","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll, D. M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252\u2013264 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnrgastro2016154_CR154","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","volume":"350","author":"M Vetizou","year":"2015","unstructured":"Vetizou, M.  et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350, 1079\u20131084 (2015).","journal-title":"Science"},{"key":"BFnrgastro2016154_CR155","doi-asserted-by":"publisher","first-page":"e31391","DOI":"10.1371\/journal.pone.0031391","volume":"7","author":"K Knieke","year":"2012","unstructured":"Knieke, K., Lingel, H., Chamaon, K. & Brunner-Weinzierl, M. C. Migration of Th1 lymphocytes is regulated by CD152 (CTLA-4)-mediated signaling via PI3 kinase-dependent Akt activation. PLoS ONE 7, e31391 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2016154_CR156","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/eji.201646373","volume":"47","author":"S Garaud","year":"2017","unstructured":"Garaud, S.  et al. FOXP1 is a key regulator of quiescence in healthy human CD3+ CD4+ T Cells and is constitutively repressed in CD3\u2212 CD4+ T cells from patients with lymphoproliferative disorders. Eur. J. Immunol. 47, 168\u2013179 (2017).","journal-title":"Eur. J. Immunol."},{"key":"BFnrgastro2016154_CR157","doi-asserted-by":"publisher","first-page":"11114","DOI":"10.1074\/jbc.M109.063313","volume":"285","author":"Y Nagai","year":"2010","unstructured":"Nagai, Y., Nishimura, A., Tago, K., Mizuno, N. & Itoh, H. Ric-8B stabilizes the alpha subunit of stimulatory G protein by inhibiting its ubiquitination. J. Biol. Chem. 285, 11114\u201311120 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro2016154_CR158","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1476-9255-3-13","volume":"3","author":"RI Krutilina","year":"2006","unstructured":"Krutilina, R. I., Kropotov, A. V., Leutenegger, C. & Serikov, V. B. Migrating leukocytes are the source of peroxiredoxin V during inflammation in the airways. J. Inflamm. (Lond.) 3, 13 (2006).","journal-title":"J. Inflamm. (Lond.)"},{"key":"BFnrgastro2016154_CR159","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.freeradbiomed.2013.06.038","volume":"65","author":"HI Choi","year":"2013","unstructured":"Choi, H. I.  et al. Peroxiredoxin V selectively regulates IL-6 production by modulating the Jak2-Stat5 pathway. Free Radic. Biol. Med. 65, 270\u2013279 (2013).","journal-title":"Free Radic. Biol. Med."},{"key":"BFnrgastro2016154_CR160","doi-asserted-by":"publisher","first-page":"e0149266","DOI":"10.1371\/journal.pone.0149266","volume":"11","author":"HI Choi","year":"2016","unstructured":"Choi, H. I., Ma, S. K., Bae, E. H., Lee, J. & Kim, S. W. Peroxiredoxin 5 protects TGF-beta induced fibrosis by inhibiting Stat3 activation in rat kidney interstitial fibroblast cells. PLoS ONE 11, e0149266 (2016).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2016154_CR161","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/hep.24525","volume":"54","author":"YD Wang","year":"2011","unstructured":"Wang, Y. D., Chen, W. D., Yu, D., Forman, B. M. & Huang, W. The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-kappaB) in mice. Hepatology 54, 1421\u20131432 (2011).","journal-title":"Hepatology"},{"key":"BFnrgastro2016154_CR162","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3389\/fphar.2015.00287","volume":"6","author":"C Guo","year":"2015","unstructured":"Guo, C.  et al. The G-protein-coupled bile acid receptor Gpbar1 (TGR5) inhibits gastric inflammation through antagonizing NF-kappaB signaling pathway. Front. Pharmacol. 6, 287 (2015).","journal-title":"Front. Pharmacol."},{"key":"BFnrgastro2016154_CR163","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/hep.24537","volume":"54","author":"A Baghdasaryan","year":"2011","unstructured":"Baghdasaryan, A.  et al. Dual farnesoid X receptor\/TGR5 agonist INT-767 reduces liver injury in the Mdr2\u2212\/\u2212 (Abcb4\u2212\/\u2212) mouse cholangiopathy model by promoting biliary HCO(-)(3) output. Hepatology 54, 1303\u20131312 (2011).","journal-title":"Hepatology"},{"key":"BFnrgastro2016154_CR164","doi-asserted-by":"publisher","first-page":"E58","DOI":"10.1002\/ibd.23017","volume":"19","author":"J Wagner","year":"2013","unstructured":"Wagner, J., Catto-Smith, A. G., Cameron, D. J. & Kirkwood, C. D. Pseudomonas infection in children with early-onset Crohn's disease: an association with a mutation close to PSMG1. Inflamm. Bowel Dis. 19, E58\u2013E59 (2013).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2016154_CR165","doi-asserted-by":"publisher","first-page":"6680","DOI":"10.1038\/sj.onc.1209954","volume":"25","author":"TD Gilmore","year":"2006","unstructured":"Gilmore, T. D. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 25, 6680\u20136684 (2006).","journal-title":"Oncogene"},{"key":"BFnrgastro2016154_CR166","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3892\/or.2012.2089","volume":"29","author":"Y Yin","year":"2013","unstructured":"Yin, Y., Si, X., Gao, Y., Gao, L. & Wang, J. The nuclear factor-kappaB correlates with increased expression of interleukin-6 and promotes progression of gastric carcinoma. Oncol. Rep. 29, 34\u201338 (2013).","journal-title":"Oncol. Rep."},{"key":"BFnrgastro2016154_CR167","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1177\/1947601911421925","volume":"2","author":"TD Gilmore","year":"2011","unstructured":"Gilmore, T. D. & Gerondakis, S. The c-Rel transcription factor in development and disease. Genes Cancer 2, 695\u2013711 (2011).","journal-title":"Genes Cancer"},{"key":"BFnrgastro2016154_CR168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.2015.410","volume":"114","author":"JE Hunter","year":"2016","unstructured":"Hunter, J. E., Leslie, J. & Perkins, N. D. c-Rel and its many roles in cancer: an old story with new twists. Br. J. Cancer 114, 1\u20136 (2016).","journal-title":"Br. J. Cancer"},{"key":"BFnrgastro2016154_CR169","doi-asserted-by":"publisher","first-page":"5692","DOI":"10.1093\/emboj\/20.20.5692","volume":"20","author":"SW Kang","year":"2001","unstructured":"Kang, S. W.  et al. PKCbeta modulates antigen receptor signaling via regulation of Btk membrane localization. EMBO J. 20, 5692\u20135702 (2001).","journal-title":"EMBO J."},{"key":"BFnrgastro2016154_CR170","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/hep.22591","volume":"49","author":"W Hsu","year":"2009","unstructured":"Hsu, W.  et al. Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(\u2212\/\u2212) mice. Hepatology 49, 133\u2013140 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro2016154_CR171","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.expneurol.2014.04.015","volume":"262","author":"N Pfender","year":"2014","unstructured":"Pfender, N. & Martin, R. Daclizumab (anti-CD25) in multiple sclerosis. Exp. Neurol. 262, 44\u201351 (2014).","journal-title":"Exp. Neurol."},{"key":"BFnrgastro2016154_CR172","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1042\/BJ20101188","volume":"432","author":"SA Matthews","year":"2010","unstructured":"Matthews, S. A.  et al. Unique functions for protein kinase D1 and protein kinase D2 in mammalian cells. Biochem. J. 432, 153\u2013163 (2010).","journal-title":"Biochem. J."},{"key":"BFnrgastro2016154_CR173","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1084\/jem.20042034","volume":"201","author":"F Dequiedt","year":"2005","unstructured":"Dequiedt, F.  et al. Phosphorylation of histone deacetylase 7 by protein kinase D mediates T cell receptor-induced Nur77 expression and apoptosis. J. Exp. Med. 201, 793\u2013804 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnrgastro2016154_CR174","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ni.2008","volume":"12","author":"MN Navarro","year":"2011","unstructured":"Navarro, M. N., Goebel, J., Feijoo-Carnero, C., Morrice, N. & Cantrell, D. A. Phosphoproteomic analysis reveals an intrinsic pathway for the regulation of histone deacetylase 7 that controls the function of cytotoxic T lymphocytes. Nat. Immunol. 12, 352\u2013361 (2011).","journal-title":"Nat. Immunol."},{"key":"BFnrgastro2016154_CR175","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cell.2006.05.040","volume":"126","author":"S Chang","year":"2006","unstructured":"Chang, S.  et al. Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. Cell 126, 321\u2013334 (2006).","journal-title":"Cell"},{"key":"BFnrgastro2016154_CR176","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.1074\/jbc.M113.456996","volume":"288","author":"DR Walkinshaw","year":"2013","unstructured":"Walkinshaw, D. R.  et al. The tumor suppressor kinase LKB1 activates the downstream kinases SIK2 and SIK3 to stimulate nuclear export of class IIa histone deacetylases. J. Biol. Chem. 288, 9345\u20139362 (2013).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro2016154_CR177","doi-asserted-by":"publisher","first-page":"16986","DOI":"10.1073\/pnas.1215450109","volume":"109","author":"K Clark","year":"2012","unstructured":"Clark, K.  et al. Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages. Proc. Natl Acad. Sci. USA 109, 16986\u201316991 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2016154_CR178","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1172\/JCI41624","volume":"120","author":"J Bricambert","year":"2010","unstructured":"Bricambert, J.  et al. Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. J. Clin. Invest. 120, 4316\u20134331 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro2016154_CR179","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1038\/jid.2015.110","volume":"135","author":"R Herro","year":"2015","unstructured":"Herro, R., Antunes Rda, S., Aguilera, A. R., Tamada, K. & Croft, M. The tumor necrosis factor superfamily molecule LIGHT promotes keratinocyte activity and skin fibrosis. J. Invest. Dermatol. 135, 2109\u20132118 (2015).","journal-title":"J. Invest. Dermatol."},{"key":"BFnrgastro2016154_CR180","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/ni1554","volume":"9","author":"G Cai","year":"2008","unstructured":"Cai, G.  et al. CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat. Immunol. 9, 176\u2013185 (2008).","journal-title":"Nat. Immunol."},{"key":"BFnrgastro2016154_CR181","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.imlet.2013.01.008","volume":"151","author":"C Pasero","year":"2013","unstructured":"Pasero, C. & Olive, D. Interfering with coinhibitory molecules: BTLA\/HVEM as new targets to enhance anti-tumor immunity. Immunol. Lett. 151, 71\u201375 (2013).","journal-title":"Immunol. Lett."},{"key":"BFnrgastro2016154_CR182","doi-asserted-by":"publisher","first-page":"943149","DOI":"10.1155\/2014\/943149","volume":"2014","author":"R Takahashi","year":"2014","unstructured":"Takahashi, R. & Yoshimura, A. SOCS1 and regulation of regulatory T cells plasticity. J. Immunol. Res. 2014, 943149 (2014).","journal-title":"J. Immunol. Res."},{"key":"BFnrgastro2016154_CR183","first-page":"183","volume":"6","author":"CM Ahmed","year":"2015","unstructured":"Ahmed, C. M., Larkin, J. III & Johnson, H. M. SOCS1 mimetics and antagonists: a complementary approach to positive and negative regulation of immune function. Front. Immunol. 6, 183 (2015).","journal-title":"Front. Immunol."},{"key":"BFnrgastro2016154_CR184","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1172\/JCI76327","volume":"125","author":"MA Saleh","year":"2015","unstructured":"Saleh, M. A.  et al. Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation. J. Clin. Invest. 125, 1189\u20131202 (2015).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro2016154_CR185","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1172\/JCI81468","volume":"126","author":"Y Cheng","year":"2016","unstructured":"Cheng, Y.  et al. LNK\/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors. J. Clin. Invest. 126, 1267\u20131281 (2016).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro2016154_CR186","doi-asserted-by":"publisher","first-page":"e21381","DOI":"10.1371\/journal.pone.0021381","volume":"6","author":"HW Zimmermann","year":"2011","unstructured":"Zimmermann, H. W.  et al. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS ONE 6, e21381 (2011).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2016154_CR187","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH732>3.0.CO;2-X","volume":"192","author":"EJ Williams","year":"2000","unstructured":"Williams, E. J.  et al. Distribution of the interleukin-8 receptors, CXCR1 and CXCR2, in inflamed gut tissue. J. Pathol. 192, 533\u2013539 (2000).","journal-title":"J. Pathol."},{"key":"BFnrgastro2016154_CR188","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s00262-012-1245-1","volume":"61","author":"S Sapoznik","year":"2012","unstructured":"Sapoznik, S.  et al. CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapy. Cancer Immunol. Immunother. 61, 1833\u20131847 (2012).","journal-title":"Cancer Immunol. Immunother."},{"key":"BFnrgastro2016154_CR189","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1158\/1535-7163.MCT-14-0448","volume":"13","author":"M Lv","year":"2014","unstructured":"Lv, M.  et al. miR141-CXCL1-CXCR2 signaling-induced Treg recruitment regulates metastases and survival of non-small cell lung cancer. Mol. Cancer Ther. 13, 3152\u20133162 (2014).","journal-title":"Mol. Cancer Ther."},{"key":"BFnrgastro2016154_CR190","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0092-8674(03)00120-X","volume":"112","author":"TD Pollard","year":"2003","unstructured":"Pollard, T. D. & Borisy, G. G. Cellular motility driven by assembly and disassembly of actin filaments. Cell 112, 453\u2013465 (2003).","journal-title":"Cell"},{"key":"BFnrgastro2016154_CR191","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1042\/BJ20121803","volume":"452","author":"M Willett","year":"2013","unstructured":"Willett, M., Brocard, M., Pollard, H. J. & Morley, S. J. mRNA encoding WAVE-Arp2\/3-associated proteins is co-localized with foci of active protein synthesis at the leading edge of MRC5 fibroblasts during cell migration. Biochem. J. 452, 45\u201355 (2013).","journal-title":"Biochem. J."},{"key":"BFnrgastro2016154_CR192","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.cellsig.2006.08.002","volume":"19","author":"C Sanchez-Valdepenas","year":"2007","unstructured":"Sanchez-Valdepenas, C., Punzon, C., San-Antonio, B., Martin, A. G. & Fresno, M. Differential regulation of p65 and c-Rel NF-kappaB transactivating activity by Cot, protein kinase C zeta and NIK protein kinases in CD3\/CD28 activated T cells. Cell. Signal. 19, 528\u2013537 (2007).","journal-title":"Cell. Signal."},{"key":"BFnrgastro2016154_CR193","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1053\/j.gastro.2014.04.003","volume":"147","author":"E Liaskou","year":"2014","unstructured":"Liaskou, E.  et al. Loss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis. Gastroenterology 147, 221\u2013232.e7 (2014).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016154_CR194","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1084\/jem.20030958","volume":"198","author":"K Shibuya","year":"2003","unstructured":"Shibuya, K.  et al. CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation. J. Exp. Med. 198, 1829\u20131839 (2003).","journal-title":"J. Exp. Med."},{"key":"BFnrgastro2016154_CR195","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1084\/jem.20081752","volume":"205","author":"S Gilfillan","year":"2008","unstructured":"Gilfillan, S.  et al. DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors. J. Exp. Med. 205, 2965\u20132973 (2008).","journal-title":"J. Exp. Med."},{"key":"BFnrgastro2016154_CR196","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/ni.2850","volume":"15","author":"CJ Chan","year":"2014","unstructured":"Chan, C. J.  et al. The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions. Nat. Immunol. 15, 431\u2013438 (2014).","journal-title":"Nat. Immunol."},{"key":"BFnrgastro2016154_CR197","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1084\/jem.20140455","volume":"211","author":"JM Kennedy","year":"2014","unstructured":"Kennedy, J. M.  et al. CCDC88B is a novel regulator of maturation and effector functions of T cells during pathological inflammation. J. Exp. Med. 211, 2519\u20132535 (2014).","journal-title":"J. Exp. Med."},{"key":"BFnrgastro2016154_CR198","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1002\/1521-4141(200010)30:10<2857::AID-IMMU2857>3.0.CO;2-G","volume":"30","author":"I Bergqvist","year":"2000","unstructured":"Bergqvist, I.  et al. The basic helix-loop-helix transcription factor E2-2 is involved in T lymphocyte development. Eur. J. Immunol. 30, 2857\u20132863 (2000).","journal-title":"Eur. J. Immunol."},{"key":"BFnrgastro2016154_CR199","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2008.09.016","volume":"135","author":"B Cisse","year":"2008","unstructured":"Cisse, B.  et al. Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 135, 37\u201348 (2008).","journal-title":"Cell"},{"key":"BFnrgastro2016154_CR200","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/mi.2014.122","volume":"8","author":"MR Spalinger","year":"2015","unstructured":"Spalinger, M. R.  et al. PTPN2 controls differentiation of CD4+ T cells and limits intestinal inflammation and intestinal dysbiosis. Mucosal Immunol. 8, 918\u2013929 (2015).","journal-title":"Mucosal Immunol."},{"key":"BFnrgastro2016154_CR201","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1172\/JCI59492","volume":"121","author":"F Wiede","year":"2011","unstructured":"Wiede, F.  et al. T cell protein tyrosine phosphatase attenuates T cell signaling to maintain tolerance in mice. J. Clin. Invest. 121, 4758\u20134774 (2011).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro2016154_CR202","doi-asserted-by":"publisher","first-page":"8576","DOI":"10.1038\/ncomms9576","volume":"6","author":"E Bothur","year":"2016","unstructured":"Bothur, E.  et al. Antigen receptor-mediated depletion of FOXP3 in induced regulatory T-lymphocytes via PTPN2 and FOXO1. Nat. Commun. 6, 8576 (2016).","journal-title":"Nat. Commun."},{"key":"BFnrgastro2016154_CR203","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nri1568","volume":"5","author":"A Strasser","year":"2005","unstructured":"Strasser, A. The role of BH3-only proteins in the immune system. Nat. Rev. Immunol. 5, 189\u2013200 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrgastro2016154_CR204","doi-asserted-by":"publisher","first-page":"23058","DOI":"10.18632\/oncotarget.5492","volume":"6","author":"RV Sionov","year":"2015","unstructured":"Sionov, R. V., Vlahopoulos, S. A. & Granot, Z. Regulation of Bim in health and disease. Oncotarget 6, 23058\u201323134 (2015).","journal-title":"Oncotarget"},{"key":"BFnrgastro2016154_CR205","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jphysparis.2005.12.006","volume":"99","author":"M Benoist","year":"2006","unstructured":"Benoist, M., Gaillard, S. & Castets, F. The striatin family: a new signaling platform in dendritic spines. J. Physiol. Paris 99, 146\u2013153 (2006).","journal-title":"J. Physiol. Paris"},{"key":"BFnrgastro2016154_CR206","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1111\/cas.12541","volume":"105","author":"M Wong","year":"2014","unstructured":"Wong, M.  et al. Silencing of STRN4 suppresses the malignant characteristics of cancer cells. Cancer Sci. 105, 1526\u20131532 (2014).","journal-title":"Cancer Sci."},{"key":"BFnrgastro2016154_CR207","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/iub.36","volume":"60","author":"AY Tsygankov","year":"2008","unstructured":"Tsygankov, A. Y. Multidomain STS\/TULA proteins are novel cellular regulators. IUBMB Life 60, 224\u2013231 (2008).","journal-title":"IUBMB Life"},{"key":"BFnrgastro2016154_CR208","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/icb.2014.60","volume":"92","author":"TN Newman","year":"2014","unstructured":"Newman, T. N.  et al. Members of the novel UBASH3\/STS\/TULA family of cellular regulators suppress T-cell-driven inflammatory responses in vivo. Immunol. Cell Biol. 92, 837\u2013850 (2014).","journal-title":"Immunol. Cell Biol."},{"key":"BFnrgastro2016154_CR209","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.cell.2014.05.016","volume":"157","author":"SA Soleimanpour","year":"2014","unstructured":"Soleimanpour, S. A.  et al. The diabetes susceptibility gene Clec16a regulates mitophagy. Cell 157, 1577\u20131590 (2014).","journal-title":"Cell"},{"key":"BFnrgastro2016154_CR210","doi-asserted-by":"publisher","first-page":"6804","DOI":"10.1038\/ncomms7804","volume":"6","author":"J Li","year":"2015","unstructured":"Li, J.  et al. Association of CLEC16A with human common variable immunodeficiency disorder and role in murine B cells. Nat. Commun. 6, 6804 (2015).","journal-title":"Nat. Commun."},{"key":"BFnrgastro2016154_CR211","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1093\/hmg\/ddn035","volume":"17","author":"I Lastres-Becker","year":"2008","unstructured":"Lastres-Becker, I.  et al. Insulin receptor and lipid metabolism pathology in ataxin-2 knock-out mice. Hum. Mol. Genet. 17, 1465\u20131481 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrgastro2016154_CR212","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1074\/mcp.M115.056770","volume":"15","author":"D Meierhofer","year":"2016","unstructured":"Meierhofer, D., Halbach, M., Sen, N. E., Gispert, S. & Auburger, G. Atxn2-knock-out mice show branched chain amino acids and fatty acids pathway alterations. Mol. Cell. Proteomics 15, 1728\u20131739 (2016).","journal-title":"Mol. Cell. Proteomics"},{"key":"BFnrgastro2016154_CR213","doi-asserted-by":"publisher","first-page":"511","DOI":"10.5483\/BMBRep.2009.42.8.511","volume":"42","author":"SY Park","year":"2009","unstructured":"Park, S. Y.  et al. DOBI is cleaved by caspases during TRAIL-induced apoptotic cell death. BMB Rep. 42, 511\u2013515 (2009).","journal-title":"BMB Rep."},{"key":"BFnrgastro2016154_CR214","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/hep.27239","volume":"60","author":"F Wang","year":"2014","unstructured":"Wang, F.  et al. Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2. Hepatology 60, 1278\u20131290 (2014).","journal-title":"Hepatology"},{"key":"BFnrgastro2016154_CR215","doi-asserted-by":"publisher","first-page":"19030","DOI":"10.1073\/pnas.1106408108","volume":"108","author":"P Rausch","year":"2011","unstructured":"Rausch, P.  et al. Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype. Proc. Natl Acad. Sci. USA 108, 19030\u201319035 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2016154_CR216","doi-asserted-by":"publisher","first-page":"389537","DOI":"10.1155\/2013\/389537","volume":"2013","author":"JH Tabibian","year":"2013","unstructured":"Tabibian, J. H., Talwalkar, J. A. & Lindor, K. D. Role of the microbiota and antibiotics in primary sclerosing cholangitis. Biomed. Res. Int. 2013, 389537 (2013).","journal-title":"Biomed. Res. Int."},{"key":"BFnrgastro2016154_CR217","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1002\/hep.20457","volume":"40","author":"M Farkkila","year":"2004","unstructured":"Farkkila, M.  et al. Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial. Hepatology 40, 1379\u20131386 (2004).","journal-title":"Hepatology"},{"key":"BFnrgastro2016154_CR218","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/ajg.2008.14","volume":"104","author":"MG Silveira","year":"2009","unstructured":"Silveira, M. G.  et al. Minocycline in the treatment of patients with primary sclerosing cholangitis: results of a pilot study. Am. J. Gastroenterol. 104, 83\u201388 (2009).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2016154_CR219","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/apt.12232","volume":"37","author":"JH Tabibian","year":"2013","unstructured":"Tabibian, J. H.  et al. Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis \u2014 a pilot study. Aliment. Pharmacol. Ther. 37, 604\u2013612 (2013).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2016154_CR220","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/hep.28256","volume":"63","author":"CY Ponsioen","year":"2016","unstructured":"Ponsioen, C. Y.  et al. Surrogate endpoints for clinical trials in primary sclerosing cholangitis: review and results from an International PSC Study Group consensus process. Hepatology 63, 1357\u20131367 (2016).","journal-title":"Hepatology"},{"key":"BFnrgastro2016154_CR221","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1053\/gast.1996.v110.pm8613073","volume":"110","author":"G Alpini","year":"1996","unstructured":"Alpini, G.  et al. Morphological, molecular, and functional heterogeneity of cholangiocytes from normal rat liver. Gastroenterology 110, 1636\u20131643 (1996).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016154_CR222","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1055\/s-2002-34501","volume":"22","author":"M Marzioni","year":"2002","unstructured":"Marzioni, M.  et al. Functional heterogeneity of cholangiocytes. Semin. Liver Dis. 22, 227\u2013240 (2002).","journal-title":"Semin. Liver Dis."},{"key":"BFnrgastro2016154_CR223","doi-asserted-by":"publisher","first-page":"G769","DOI":"10.1152\/ajpgi.00237.2010","volume":"299","author":"S Glaser","year":"2010","unstructured":"Glaser, S.  et al. Differential transcriptional characteristics of small and large biliary epithelial cells derived from small and large bile ducts. Am. J. Physiol. Gastrointest. Liver Physiol. 299, G769\u2013G777 (2010).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro2016154_CR224","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jcmgh.2015.05.005","volume":"1","author":"L Maroni","year":"2015","unstructured":"Maroni, L.  et al. Functional and structural features of cholangiocytes in health and disease. Cell. Mol. Gastroenterol. Hepatol. 1, 368\u2013380 (2015).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016154_CR225","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/hep.27840","volume":"62","author":"E Schrumpf","year":"2015","unstructured":"Schrumpf, E.  et al. The biliary epithelium presents antigens to and activates natural killer T cells. Hepatology 62, 1249\u20131259 (2015).","journal-title":"Hepatology"},{"key":"BFnrgastro2016154_CR226","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s004280050077","volume":"431","author":"HP Dienes","year":"1997","unstructured":"Dienes, H. P.  et al. Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis. Virchows Arch. 431, 119\u2013124 (1997).","journal-title":"Virchows Arch."},{"key":"BFnrgastro2016154_CR227","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3109\/00365529309096058","volume":"28","author":"U Broome","year":"1993","unstructured":"Broome, U., Hultcrantz, R. & Scheynius, A. Lack of concomitant expression of ICAM-1 and HLA-DR on bile duct cells from patients with primary sclerosing cholangitis and primary biliary cirrhosis. Scand. J. Gastroenterol. 28, 126\u2013130 (1993).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro2016154_CR228","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/hep.23405","volume":"51","author":"JA Dranoff","year":"2010","unstructured":"Dranoff, J. A. & Wells, R. G. Portal fibroblasts: underappreciated mediators of biliary fibrosis. Hepatology 51, 1438\u20131444 (2010).","journal-title":"Hepatology"},{"key":"BFnrgastro2016154_CR229","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1038\/ncomms3823","volume":"4","author":"I Mederacke","year":"2013","unstructured":"Mederacke, I.  et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat. Commun. 4, 2823 (2013).","journal-title":"Nat. Commun."},{"key":"BFnrgastro2016154_CR230","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1053\/j.gastro.2014.05.001","volume":"147","author":"RG Wells","year":"2014","unstructured":"Wells, R. G. The portal fibroblast: not just a poor man's stellate cell. Gastroenterology 147, 41\u201347 (2014).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016154_CR231","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.jhep.2016.01.010","volume":"64","author":"I Lua","year":"2016","unstructured":"Lua, I.  et al. Characterization of hepatic stellate cells, portal fibroblasts, and mesothelial cells in normal and fibrotic livers. J. Hepatol. 64, 1137\u20131146 (2016).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016154_CR232","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/hep.24691","volume":"55","author":"S Hohenester","year":"2012","unstructured":"Hohenester, S.  et al. A biliary HCO3\u2212 umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes. Hepatology 55, 173\u2013183 (2012).","journal-title":"Hepatology"},{"key":"BFnrgastro2016154_CR233","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1093\/ecco-jcc\/jjw019.007","volume":"10","author":"R Alberts","year":"2016","unstructured":"Alberts, R.  et al. Genotype-phenotype analysis across 130 422 genetic variants identifies RSPO3 as the first genome-wide significant modifier gene in primary sclerosing cholangitis. J. Crohns Colitis 10, S5\u2013S7 (2016).","journal-title":"J. Crohns Colitis"},{"key":"BFnrgastro2016154_CR234","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1042\/BST0341119","volume":"34","author":"MC Wright","year":"2006","unstructured":"Wright, M. C. The impact of pregnane X receptor activation on liver fibrosis. Biochem. Soc. Trans. 34, 1119\u20131123 (2006).","journal-title":"Biochem. Soc. Trans."},{"key":"BFnrgastro2016154_CR235","first-page":"S54","volume":"33","author":"O Boyman","year":"2015","unstructured":"Boyman, O., Kolios, A. G. & Raeber, M. E. Modulation of T cell responses by IL-2 and IL-2 complexes. Clin. Exp. Rheumatol. 33, S54\u2013S57 (2015).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrgastro2016154_CR236","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1136\/gut.49.1.131","volume":"49","author":"X Bo","year":"2001","unstructured":"Bo, X., Broome, U., Remberger, M. & Sumitran-Holgersson, S. Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis. Gut 49, 131\u2013141 (2001).","journal-title":"Gut"},{"key":"BFnrgastro2016154_CR237","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/nri3407","volume":"13","author":"LM Sollid","year":"2013","unstructured":"Sollid, L. M. & Jabri, B. Triggers and drivers of autoimmunity: lessons from coeliac disease. Nat. Rev. Immunol. 13, 294\u2013302 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrgastro2016154_CR238","unstructured":"US National Library of Medicine. ClinicalTrials.gov [online], \n                    https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01984047\n                    \n                   (2015)."},{"key":"BFnrgastro2016154_CR239","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","volume":"360","author":"GM Hirschfield","year":"2009","unstructured":"Hirschfield, G. M.  et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N. Engl. J. Med. 360, 2544\u20132555 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2016154_CR240","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/hep.28359","volume":"64","author":"GM Hirschfield","year":"2016","unstructured":"Hirschfield, G. M.  et al. Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: a proof-of-concept study. Hepatology 64, 189\u2013199 (2016).","journal-title":"Hepatology"},{"key":"BFnrgastro2016154_CR241","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nature15819","volume":"526","author":"AV Biankin","year":"2015","unstructured":"Biankin, A. V., Piantadosi, S. & Hollingsworth, S. J. Patient-centric trials for therapeutic development in precision oncology. Nature 526, 361\u2013370 (2015).","journal-title":"Nature"},{"key":"BFnrgastro2016154_CR242","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature13394","volume":"511","author":"C Gilissen","year":"2014","unstructured":"Gilissen, C.  et al. Genome sequencing identifies major causes of severe intellectual disability. Nature 511, 344\u2013347 (2014).","journal-title":"Nature"},{"key":"BFnrgastro2016154_CR243","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrg.2016.12","volume":"17","author":"MR Nelson","year":"2016","unstructured":"Nelson, M. R.  et al. The genetics of drug efficacy: opportunities and challenges. Nat. Rev. Genet. 17, 197\u2013206 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"BFnrgastro2016154_CR244","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrg2751","volume":"11","author":"AK Daly","year":"2010","unstructured":"Daly, A. K. Genome-wide association studies in pharmacogenomics. Nat. Rev. Genet. 11, 241\u2013246 (2010).","journal-title":"Nat. Rev. Genet."},{"key":"BFnrgastro2016154_CR245","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/ng.3281","volume":"47","author":"VK Wong","year":"2015","unstructured":"Wong, V. K.  et al. Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events. Nat. Genet. 47, 632\u2013639 (2015).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR246","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/ng.2878","volume":"46","author":"N Casali","year":"2014","unstructured":"Casali, N.  et al. Evolution and transmission of drug-resistant tuberculosis in a Russian population. Nat. Genet. 46, 279\u2013286 (2014).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR247","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/ng.2478","volume":"45","author":"M He","year":"2013","unstructured":"He, M.  et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat. Genet. 45, 109\u2013113 (2013).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR248","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1002\/hep.23564","volume":"51","author":"TH Karlsen","year":"2010","unstructured":"Karlsen, T. H., Melum, E. & Franke, A. The utility of genome-wide association studies in hepatology. Hepatology 51, 1833\u20131842 (2010).","journal-title":"Hepatology"},{"key":"BFnrgastro2016154_CR249","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1177\/1352458516635873","volume":"22","author":"Y Wang","year":"2016","unstructured":"Wang, Y.  et al. Genetic overlap between multiple sclerosis and several cardiovascular disease risk factors. Mult. Scler. 22, 1783\u20131793 (2016).","journal-title":"Mult. Scler."},{"key":"BFnrgastro2016154_CR250","doi-asserted-by":"publisher","first-page":"e0123057","DOI":"10.1371\/journal.pone.0123057","volume":"10","author":"OA Andreassen","year":"2015","unstructured":"Andreassen, O. A.  et al. Abundant genetic overlap between blood lipids and immune-mediated diseases indicates shared molecular genetic mechanisms. PLoS ONE 10, e0123057 (2015).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2016154_CR251","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1136\/gut.2008.157818","volume":"59","author":"B Terjung","year":"2010","unstructured":"Terjung, B.  et al. p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ. Gut 59, 808\u2013816 (2010).","journal-title":"Gut"},{"key":"BFnrgastro2016154_CR252","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ng.379","volume":"41","author":"AK Daly","year":"2009","unstructured":"Daly, A. K.  et al. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat. Genet. 41, 816\u2013819 (2009).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR253","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/ng.632","volume":"42","author":"JB Singer","year":"2010","unstructured":"Singer, J. B.  et al. A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury. Nat. Genet. 42, 711\u2013714 (2010).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2016154_CR254","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1053\/j.gastro.2011.04.001","volume":"141","author":"MI Lucena","year":"2011","unstructured":"Lucena, M. I.  et al. Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology 141, 338\u2013347 (2011).","journal-title":"Gastroenterology"}],"container-title":["Nature Reviews Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2016.154.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2016.154","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nrgastro.2016.154","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2016.154.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:55:13Z","timestamp":1684454113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2016.154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,15]]},"references-count":254,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["BFnrgastro2016154"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2016.154","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,15]]},"assertion":[{"value":"15 March 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2017","order":2,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of this article initially published online, a line in the legend of Figure 3 and an attribution in the Acknowledgements were incorrect. The errors have been corrected for the print, HTML and PDF versions of the article.","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}